2023 Q2 Form 10-Q Financial Statement

#000121390023039889 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $40.00K $64.00K $394.0K
YoY Change -94.03% -83.76% 71.3%
Cost Of Revenue $153.0K $123.0K $260.0K
YoY Change -75.12% -52.69% 4.0%
Gross Profit -$113.0K -$59.00K $134.0K
YoY Change -305.45% -144.03% -770.0%
Gross Profit Margin -282.5% -92.19% 34.01%
Selling, General & Admin $776.0K $1.625M $3.289M
YoY Change -71.72% -50.59% 188.51%
% of Gross Profit 2454.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.000K $2.000K $453.0K
YoY Change -98.89% -99.56% 0.67%
% of Gross Profit 338.06%
Operating Expenses $780.0K $1.627M $3.742M
YoY Change -75.59% -56.52% 135.35%
Operating Profit -$893.0K -$1.686M -$3.608M
YoY Change -71.57% -53.27% 124.1%
Interest Expense -$7.000K -$1.000K -$1.000K
YoY Change -333.33% 0.0% -99.17%
% of Operating Profit
Other Income/Expense, Net -$517.0K $65.00K
YoY Change 1420.59%
Pretax Income -$1.403M -$1.686M -$3.609M
YoY Change -55.81% -53.28% 114.82%
Income Tax
% Of Pretax Income
Net Earnings -$1.412M -$1.695M -$3.624M
YoY Change -55.68% -53.23% 115.71%
Net Earnings / Revenue -3530.0% -2648.44% -919.8%
Basic Earnings Per Share -$0.67 -$1.00 -$3.15
Diluted Earnings Per Share -$0.67 -$1.00 -$242.2K
COMMON SHARES
Basic Shares Outstanding 2.103M shares 2.104M shares 1.151M shares
Diluted Shares Outstanding 2.103M shares 1.696M shares 1.151M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $271.0K $3.328M $4.335M
YoY Change -84.93% -23.23% -33.61%
Cash & Equivalents $271.0K $3.328M $4.335M
Short-Term Investments
Other Short-Term Assets $36.00K $52.00K $192.0K
YoY Change -63.64% -72.92% 28.0%
Inventory
Prepaid Expenses
Receivables $233.0K $221.0K $92.00K
Other Receivables $311.0K $88.00K $0.00
Total Short-Term Assets $628.0K $3.689M $4.619M
YoY Change -69.0% -20.13% -31.37%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000K $6.000K $9.000K
YoY Change -44.44% -33.33%
Goodwill
YoY Change
Intangibles $100.0K $26.00K
YoY Change -97.79%
Long-Term Investments $3.000M $1.468M $63.00K
YoY Change 232.59% 2230.16%
Other Assets
YoY Change
Total Long-Term Assets $3.105M $1.500M $5.057M
YoY Change -42.96% -70.34% -25.63%
TOTAL ASSETS
Total Short-Term Assets $628.0K $3.689M $4.619M
Total Long-Term Assets $3.105M $1.500M $5.057M
Total Assets $3.733M $5.189M $9.676M
YoY Change -50.03% -46.37% -28.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.286M $1.224M $1.537M
YoY Change -32.99% -20.36% 9.79%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $115.0K $112.0K $100.0K
YoY Change 11.65% 12.0% -70.59%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.173M $2.221M $3.224M
YoY Change -38.56% -31.11% -0.8%
LONG-TERM LIABILITIES
Long-Term Debt $89.00K $89.00K $89.00K
YoY Change 0.0% 0.0% -1.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $89.00K $89.00K $89.00K
YoY Change 0.0% 0.0% -1.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.173M $2.221M $3.224M
Total Long-Term Liabilities $89.00K $89.00K $89.00K
Total Liabilities $2.262M $2.310M $3.313M
YoY Change -37.62% -30.27% -0.81%
SHAREHOLDERS EQUITY
Retained Earnings -$55.86M -$54.45M
YoY Change 24.05%
Common Stock $2.000K $2.000K
YoY Change -86.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $33.00K $33.00K
YoY Change
Treasury Stock Shares
Shareholders Equity $1.471M $2.879M $6.363M
YoY Change
Total Liabilities & Shareholders Equity $3.733M $5.189M $9.676M
YoY Change -50.03% -46.37% -28.48%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.412M -$1.695M -$3.624M
YoY Change -55.68% -53.23% 115.71%
Depreciation, Depletion And Amortization $5.000K $2.000K $453.0K
YoY Change -98.89% -99.56% 0.67%
Cash From Operating Activities -$900.0K -$1.453M -$2.225M
YoY Change -53.12% -34.7% -33.78%
INVESTING ACTIVITIES
Capital Expenditures $78.00K -$7.000K
YoY Change
Acquisitions $850.0K
YoY Change
Other Investing Activities -$2.079M $0.00 -$40.00K
YoY Change 236.95% -100.0% -20.0%
Cash From Investing Activities -$2.157M -$47.00K
YoY Change 249.59% -6.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $4.315M
YoY Change
NET CHANGE
Cash From Operating Activities -900.0K -$1.453M -2.225M
Cash From Investing Activities -2.157M -47.00K
Cash From Financing Activities 0.000 $4.315M
Net Change In Cash -3.057M $2.862M $0.00
YoY Change 20.5% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$900.0K -$1.453M -$2.225M
Capital Expenditures $78.00K -$7.000K
Free Cash Flow -$978.0K -$1.453M -$2.218M
YoY Change -49.06% -34.49% -33.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39973
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3537265
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
235 Lincoln Rd.
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33139
CY2023Q1 dei City Area Code
CityAreaCode
800
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
611-3622
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2103365 shares
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3328000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
466000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
177000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
177000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
221000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209000 usd
CY2023Q1 cuen Related Parties
RelatedParties
88000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
52000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
14000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3689000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
689000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1468000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
776000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28000 usd
CY2023Q1 us-gaap Assets
Assets
5189000 usd
CY2022Q4 us-gaap Assets
Assets
1499000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1224000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1231000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
775000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
681000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2103365 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2103365 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1473645 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1473645 shares
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
109000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
113000 usd
CY2023Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
112000 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
109000 usd
CY2023Q1 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
1000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2221000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2134000 usd
CY2023Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
89000 usd
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
89000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2310000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2223000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57355000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
52053000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
33000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
29000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54445000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52750000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2879000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-724000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5189000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1499000 usd
CY2023Q1 us-gaap Revenues
Revenues
64000 usd
CY2022Q1 us-gaap Revenues
Revenues
394000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
123000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
260000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-59000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
134000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
453000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1625000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3289000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1627000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3742000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1686000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3608000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1000 usd
CY2023Q1 cuen Gain On Fair Value Measurement Of Stock Based Liabilities
GainOnFairValueMeasurementOfStockBasedLiabilities
-1000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1686000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-3609000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
15000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1695000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3624000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.15
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1696022 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1151207 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-724000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
27000 usd
CY2023Q1 cuen Issuance Of Warrants
IssuanceOfWarrants
700000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
136000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
120000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1695000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2879000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
9450000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
537000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3624000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6363000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1695000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3624000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
283000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
537000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000 usd
CY2023Q1 cuen Gain From Changes In On Fair Value Of Stockbased Liabilities
GainFromChangesInOnFairValueOfStockbasedLiabilities
-1000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
453000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
81000 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
38000 usd
CY2022Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
30000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
727000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
94000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-137000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-88000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-88000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1453000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2225000 usd
CY2022Q1 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
40000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4319000 usd
CY2023Q1 cuen Purchase Of Treasury Stock
PurchaseOfTreasuryStock
4000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4315000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2862000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2272000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
466000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6607000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3328000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4335000 usd
CY2023Q1 cuen Issuance Fee With Connection To Issuance Of Common Stock Due To Exercise Of Warrants
IssuanceFeeWithConnectionToIssuanceOfCommonStockDueToExerciseOfWarrants
700000 usd
CY2022Q4 cuen Cuentas Sdi Network Of Over Bodegas
CuentasSDINetworkOfOverBodegas
31000 pure
CY2022Q4 cuen Cuentas Accountholders Expenses
CuentasAccountholdersExpenses
500000 usd
CY2005Q3 cuen Subsidiary Of Limited Liability Company Or Limited Partnerships Ownership Interests
SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipsOwnershipInterests
1 pure
CY2023Q1 cuen Purchase Agreement Description
PurchaseAgreementDescription
the Company entered into a Membership Interest Purchase Agreement (MIPA) with Core Development Holdings Corporation (“Core”). Core is a Florida corporation that holds approximately 29.3% of 4280 Lakewood Road Manager, LLC (“Lakewood Manager”), which in turn owns 86.45% of the membership interests in 4280 Lakewood Road, LLC (“4280 Project”), an affordable multi-family real estate project located in Lake Worth, Florida. Core sold 6% of its interest in the Lakewood Manager to the Company and the Company has agreed to issue to Core 295,282 of the Company’s common shares to acquire the 6% equity in the Lakewood Manager valued at approximately $700. The 295,282 of the Company’s shares were equal to 19.9% of the total number of issued and outstanding shares of the Company as of the date of the Agreement. The Company closed this transaction on or about March 9th, 2023
CY2023Q1 cuen Reverse Stock Split Description
ReverseStockSplitDescription
As a result of the reverse stock split, the following changes have occurred (i) every thirteen shares of common stock have been combined into one share of common stock; (ii) the number of shares of common stock underlying each common stock option or common stock warrant have been proportionately decreased on a 13-for-1 basis, and the exercise price of each such outstanding stock option and common warrant has been proportionately increased on a 13-for-1 basis. Accordingly, all option numbers, share numbers, warrant numbers, share prices, warrant prices, exercise prices and losses per share have been adjusted within these consolidated financial statements, on a retroactive basis, to reflect this 13-for-1 reverse stock split.
CY2023Q1 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
3328000 usd
CY2023Q1 cuen Working Capital
WorkingCapital
1468000 usd
CY2023Q1 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
2879000 usd
CY2023Q1 cuen Accumulated Deficit
AccumulatedDeficit
54445000 usd
CY2023Q1 us-gaap Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds
DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds
5000000000 usd
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
163344 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
128031 shares
CY2023Q1 us-gaap Investment Sold Not Yet Purchased Balance Shares
InvestmentSoldNotYetPurchasedBalanceShares
291375 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
17.16
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
17.16
CY2023Q1 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.0499 pure
CY2023Q1 cuen Investor Percentage
InvestorPercentage
0.0999 pure
CY2023Q1 us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
0.0013
CY2023Q1 us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
17.36
CY2023Q1 cuen Cash Fee Equal Percentage
CashFeeEqualPercentage
0.07 pure
CY2023Q1 cuen Management Fee Equal Percentage
ManagementFeeEqualPercentage
0.01 pure
CY2023Q1 us-gaap Other Expenses
OtherExpenses
65000 usd
CY2023Q1 cuen Clearing Expenses
ClearingExpenses
16000 usd
CY2021Q1 cuen Description Of License Agreement
DescriptionOfLicenseAgreement
The Company has also agreed to issue to Wainwright or its designees warrants to purchase 20,397 shares of Common Stock (the “PA Warrants” and the shares of Common Stock issuable upon exercise of the PA Warrants, the “PA Warrant Shares”).
CY2023Q1 cuen Warrant Term
WarrantTerm
P5Y
CY2023Q1 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
4300000000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
113000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
109000 usd
CY2023Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
109 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1 pure
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1000 usd
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
1000 usd
CY2022Q4 cuen Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning
128477 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.44
CY2023Q1 cuen Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitures
-6093 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
186.55
CY2023Q1 cuen Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning
122384 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.96
CY2023Q1 cuen Schedule Of Related Party Payables Net Of Discounts Text Table Block
ScheduleOfRelatedPartyPayablesNetOfDiscountsTextTableBlock
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">(dollars in thousands)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Arik Maimon (Chairman of the Board and the CEO)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">42</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Michael De Prado (Vice Chairman of the Board and President)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">SDI Cuentas LLC, net of allowance for credit losses of $157 as of March 31, 2023 and December 31,2022, respectively.</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">210</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">198</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total Due from related parties</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">298</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">198</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
298000 usd
CY2022 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
198000 usd
CY2022Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
364000 usd
CY2023Q1 us-gaap Payments For Fees
PaymentsForFees
177000 usd
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
147000 usd
CY2019Q2 us-gaap Product Liability Contingency Description
ProductLiabilityContingencyDescription
the Company received a notice of demand for arbitration from Secure IP Telecom, Inc. (“Secure IP), who allegedly had a Reciprocal Carrier Services Agreement (“RCS”) exclusively with Limecom and not with the Company. The arbitration demand originated from another demand for arbitration that Secure IP received from VoIP Capital International (“VoIP”) in March 2019, demanding $1,053 in damages allegedly caused by unpaid receivables that Limecom assigned to VoIP based on the RCS. On or about October 5, 2020, the trial court appointed a receiver over Limecom, Inc. (“Limecom”) in the matter of Spectrum Intelligence Communications Agency, LLC. v. Limecom, Inc., case no. 2018-027150-CA-01 pending in the 11th Circuit for Miami-Dade County, Florida. On June 5, 2020, Secure IP Telecom, Inc. (“Secure IP”) filed a complaint against Limecom, Heritage Ventures Limited (“Heritage”), an unrelated third party and owner of Limecom, and the Company, case no. 20-11972-CA-01. Secure IP alleges that the Company received certain transfers from Limecom during the period that the Company wholly owned Limecom that may be an avoidable under Florida Statute § 725.105. On July 13, 2021, the two cases were consolidated, and are now pending before the same trial court under the former case number. The Company has answered and denied any liability with respect to both complaints. To the extent the Company has exposure for any transfers from Limecom, Heritage has indemnified the Company for any such liability and the Company has a pending cross-claim against Heritage for purposes of enforcing the indemnification obligation. A review of the books and records of the Company reflect aggregate transfers from Limecom to the Company or its affiliates of less than $600. The Company’s books and records reflect that the Company fully reimbursed Limecom through direct payment of expenses of Limecom and through issuance of shares by the Company to employees or other vendors on behalf of Limecom for settlement and release of claims the employees or vendors may have asserted against Limecom. The books and records of the Company therefore do not reflect an identifiable avoidable transfer, but this analysis may change as the discovery process continues.
CY2023Q1 cuen Accrued Amount
AccruedAmount
300000 usd
CY2022Q4 cuen Company Financial Institution
CompanyFinancialInstitution
Crosshair Media Placement, LLC, a Kentucky based marketing company, filed and served a complaint on Cuentas for breach of contract alleging breach of contract damages of $630, which case remains pending in the United States District Court for the Western District of Kentucky, case no. 3:22-CV-512-CHB.
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
630000 usd
CY2023Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
30 usd
CY2021Q2 us-gaap Payments For Rent
PaymentsForRent
9000 usd
CY2023Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
59000 usd
CY2022Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
22000 usd
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Cuentas Inc.
CY2022Q4 cuen Related Parties
RelatedParties
usd
CY2022Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
CY2022Q1 cuen Gain On Fair Value Measurement Of Stock Based Liabilities
GainOnFairValueMeasurementOfStockBasedLiabilities
usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
usd
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.15
CY2023Q1 cuen Reverse Split
ReverseSplit
usd
CY2022Q1 cuen Gain From Changes In On Fair Value Of Stockbased Liabilities
GainFromChangesInOnFairValueOfStockbasedLiabilities
usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
CY2023Q1 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q1 cuen Purchase Of Treasury Stock
PurchaseOfTreasuryStock
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q1 cuen Issuance Fee With Connection To Issuance Of Common Stock Due To Exercise Of Warrants
IssuanceFeeWithConnectionToIssuanceOfCommonStockDueToExerciseOfWarrants
usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001424657

Files In Submission

Name View Source Status
cuen-20230331_cal.xml Edgar Link unprocessable
0001213900-23-039889-index-headers.html Edgar Link pending
0001213900-23-039889-index.html Edgar Link pending
0001213900-23-039889.txt Edgar Link pending
0001213900-23-039889-xbrl.zip Edgar Link pending
cuen-20230331.xsd Edgar Link pending
f10q0323ex31-1_cuentasinc.htm Edgar Link pending
f10q0323ex31-2_cuentasinc.htm Edgar Link pending
f10q0323ex32-1_cuentasinc.htm Edgar Link pending
f10q0323ex32-2_cuentasinc.htm Edgar Link pending
f10q0323_cuentasinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
cuen-20230331_lab.xml Edgar Link unprocessable
cuen-20230331_def.xml Edgar Link unprocessable
cuen-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0323_cuentasinc_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending